Source: Tropical Medicine & International Health. Unidade: ICB
Subjects: PARASITOLOGIA, LEISHMANIOSE CUTÂNEA
ABNT
MACHADO, Paulo R. L. et al. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, v. 23, n. 9, p. 936-942, 2018Tradução . . Disponível em: https://doi.org/10.1111/tmi.13119. Acesso em: 27 abr. 2024.APA
Machado, P. R. L., Ribeiro, C. S., França‐Costa, J., Dourado, M. E. F., Trinconi, C. T., Yokoyama‐Yasunaka, J. K. U., et al. (2018). Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial. Tropical Medicine & International Health, 23( 9), 936-942. doi:10.1111/tmi.13119NLM
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/tmi.13119Vancouver
Machado PRL, Ribeiro CS, França‐Costa J, Dourado MEF, Trinconi CT, Yokoyama‐Yasunaka JKU, Malta‐Santos H, Borges VM, Carvalho EM, Uliana SRB. Tamoxifen and meglumine antimoniate combined therapy in cutaneous leishmaniasis patients: a randomised trial [Internet]. Tropical Medicine & International Health. 2018 ; 23( 9): 936-942.[citado 2024 abr. 27 ] Available from: https://doi.org/10.1111/tmi.13119